Cargando…
Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases
BACKGROUND: Radioactive iodine 131 ((131)I) therapy has long been used in the treatment of differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications secondary to (131)I therapy are well documented, there is little in the literature addressing nasolacrimal duct obstruc...
Autores principales: | Al-Qahtani, Khalid Hussain, Al Asiri, Mushabbab, Tunio, Mutahir A, Aljohani, Naji J, Bayoumi, Yasser, Munir, Iqbal, AlAyoubi, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266423/ https://www.ncbi.nlm.nih.gov/pubmed/25525325 http://dx.doi.org/10.2147/OPTH.S71708 |
Ejemplares similares
-
Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016) -
“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015) -
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016) -
“Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015) -
Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers
por: Al-Qahtani, Khalid H., et al.
Publicado: (2015)